NCT01388595 - Fluticasone and Salmeterol in Allergic Rhinitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions

Allergic Rhinitis

Interventions

DRUG

FLUTICASONE PROPRIONATE

1\. Fluticasone Propionate (FP) Product name: Flixotide Evohaler® Manufacturer: Allan and Hanbury's Active ingredients: Fluticasone Propionate Propellant: HFA 134a Dose: 250μg per actuation giving a total dose of 500µg per day through the spacer device with the customised nasal adaptor.

DRUG

Salmeterol

Salmeterol Product Name: Serevent® Manufacturer: Allan and Hanbury's Active ingredients: Salmetrol Xinafoate Propellant: HFA 134a Dose: 25μg per actuation giving a total dose of 50µg per day through the spacer device with the customised nasal adaptor

DRUG

PLACEBO

4\. Placebo inhaler to SM, FP, SM+FP Manufacturer: Cipla Ltd Active ingredients: None Propellants: HFA 134a Imported \& QP release tested in UK : DHP Clinical supplies, Powys, UK

Trial Locations (1)

DD1 3AU

Asthma and Allergy Research Group, University of Dundee, Dundee

All Listed Sponsors

lead

University of Dundee

OTHER